Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NAX 5055

Known as: NAX-5055 
 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

GalaninLipopeptides
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The novel anticonvulsant neuropeptide and galanin analogue, NAX‐5055, does not alter energy and amino acid metabolism in cultured brain cells
A large body of evidence suggests that the neuropeptide galanin plays an important role in seizure control. In line with this, it… Expand
Is this relevant?
2016
2016
The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission
The endogenous neuropeptide galanin is ubiquitously expressed throughout the mammalian brain. Through the galanin receptors GalR1… Expand
Is this relevant?
2015
2015
Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055
The neuropeptide galanin is widely expressed in both the central and peripheral nervous systems. However there is limited… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Galanin regulates blood glucose level in the zebrafish: a morphological and functional study
The present study has demonstrated the galaninergic innervation of the endocrine pancreas including sources of the galaninergic… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2014
2014
Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms
Infantile spasms are seizures manifesting in infantile epileptic encephalopathies that are associated with poor epilepsy and… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
Epilepsy: The Next Generation Drugs (A Review)
Seizures are common and are treated in all branches of medicine. Approximately 10% of the population will have one or more… Expand
  • table 1
Is this relevant?
2011
2011
Developing novel antiepileptic drugs: Characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models
SummaryThe endogenous neuropeptide galanin and its associated receptors galanin receptor 1 and galanin receptor 2 are highly… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2010
Review
2010
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
The Tenth Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT X, took place in Eilat, Israel from the 25th to 29th of April… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2009
Review
2009
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
The Ninth Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT IX, took place in Sitges, Barcelona from the 15th to 19th of… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE